SCHEMBL7746776

SCHEMBL7746776

O=CC(C(=O)O)c1cnccn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.42
NAPRT Q6XQN6 1/20 0.42
HCAR2 Q8TDS4 1/20 0.42
LMNA P02545 2/20 0.41
ADORA3 P0DMS8 1/20 0.37
TSHR P16473 1/20 0.37
MC4R P32245 1/20 0.37
ADRA1A P35348 1/20 0.37
MC3R P41968 1/20 0.37
GAA P10253 1/20 0.33
THRB P10828 1/20 0.33
FFAR2 O15552 1/20 0.33
KMT2A Q03164 2/20 0.33
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
ALDH1A1 P00352 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
PIM2 Q9P1W9 1/20 0.31
HPGD P15428 1/20 0.31
VNN1 O95497 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10715529 0.84 KDM4E (0.41) KDM4ENAPRTHCAR2LMNAADORA3
SCHEMBL11678794 0.76 KDM4E (0.48) KDM4ENAPRTHCAR2LMNAADORA3
SCHEMBL30416431 0.76 GPR119 (0.36) KDM4ENAPRTHCAR2LMNAADORA3
SCHEMBL2558175 0.74 HSP90AA1 (0.36) KDM4ENAPRTHCAR2LMNAADORA3
SCHEMBL25660372 0.73 KDM4E (0.45) KDM4ENAPRTHCAR2LMNAADORA3
SCHEMBL6037597 0.73 LMNA (0.51) KDM4ENAPRTHCAR2LMNAADORA3
Pyrazine SCHEMBL4235261 0.73 KDM4E (0.45) KDM4ENAPRTHCAR2LMNAADORA3
SCHEMBL10484478 0.72 LMNA (0.50) KDM4ENAPRTHCAR2LMNAADORA3
SCHEMBL28114415 0.72 ADORA3 (0.47) KDM4ENAPRTHCAR2LMNAADORA3
Hydrochloric Acid SCHEMBL28153892 0.72 KDM4E (0.44) KDM4ENAPRTHCAR2LMNAADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001009118-A2 DITHIOLTHIONE COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS AND FOR MEMORY ENHANCEMENT PRENDERGAST PATRICK T (IE) 2001-02-08 WO disclosed